Sparian Biosciences Inc. has been awarded a $19.5 million, 5-year grant to fund development of SBS-226 from IND submission through phase I development. SBS-226 is a first-in-class dual μ-opioid ...
A new study published in JAMA Network Open on May 7, 2026, engaged 42 national experts in hospital-based addiction treatment in a consensus-building process to develop best practices for ...
READING, Pa. - The Council on Chemical Abuse (COCA) recently approved funding for programs and services aimed at helping prevent and treat opioid use disorder in Berks County. The contract allocations ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results